A 48-year-old man with a family history of medullary thyroid carcinoma undergoes genetic testing and is found to have a RET proto-oncogene mutation. At thyroidectomy, a tumor is identified arising from the parafollicular region. Which is the most common site of metastasis in medullary thyroid carcinoma?

Explanation

## Metastatic Pattern in Medullary Thyroid Carcinoma **Key Point:** Regional lymph nodes (cervical and mediastinal) are the most common site of metastasis in medullary thyroid carcinoma (MTC), occurring in 50% of patients at presentation or during follow-up. ### Metastatic Sites in MTC: Frequency & Timing | Metastatic Site | Frequency | Timing | | --- | --- | --- | | Regional lymph nodes | 50% | Early (often at presentation) | | Liver | 15–20% | Intermediate | | Bone | 10–15% | Late | | Lung | 8–10% | Late | | Brain | <5% | Very late | **High-Yield:** MTC has a propensity for **early lymph node involvement** because it arises from parafollicular C cells in the upper poles of the thyroid, which drain to central and lateral cervical nodes. Lymph node metastases do NOT necessarily indicate poor prognosis if detected early. ### Why Lymph Nodes Are Preferentially Involved 1. **Anatomical proximity:** Parafollicular C cells are in direct contact with lymphatic channels 2. **Tumor biology:** MTC is moderately aggressive with early lymphatic spread 3. **Calcitonin production:** Elevated serum calcitonin (>100 pg/mL) strongly suggests lymph node involvement 4. **RET mutation status:** Hereditary MTC (RET+) tends to have more aggressive lymph node disease **Clinical Pearl:** Calcitonin doubling time (CDT) predicts progression: - CDT > 6 months: indolent disease, lymph node metastases may be stable - CDT < 6 months: aggressive disease, higher risk of distant metastases ### Diagnostic Approach for Lymph Node Staging ```mermaid flowchart TD A[MTC diagnosed]:::outcome --> B[Measure serum calcitonin]:::action B --> C{Calcitonin level?}:::decision C -->|< 100 pg/mL| D[Low risk for LN mets]:::outcome C -->|100-1000 pg/mL| E[Likely central/lateral LN involvement]:::outcome C -->|> 1000 pg/mL| F[Extensive LN + possible distant mets]:::outcome D --> G[Ultrasound + consider CT/MRI]:::action E --> G F --> H[CT chest/abdomen + bone scan]:::action ``` **Mnemonic:** **RET-MTC-LN** = RET mutation → Medullary Thyroid Cancer → Lymph Node metastases (early, common) [cite:Robbins 10e Ch 24]